Completion of new corporate structure

RNS Number : 2233I
Target Healthcare REIT PLC
07 August 2019
 

Target Healthcare REIT plc

Completion of new corporate structure and first day of dealings

The Directors of Target Healthcare REIT plc (the "Company") are pleased to announce that the scheme of arrangement in connection with moving the Group's ultimate parent company to a UK domicile has now become unconditional in all respects, and has therefore become effective. The Company, a new English-incorporated company, has been established as the new parent company of Target Healthcare REIT Limited and its group of subsidiaries.

The Company's ordinary shares of £1.00 each (the "Ordinary Shares") have been admitted to the premium segment of the Official List and to trading on the main market of the London Stock Exchange with effect from 8.00 a.m. today.

For information purposes, the trading details in relation to the Company's Ordinary Shares are as follows:

TIDM:      THRL

ISIN:       GB00BJGTLF51

SEDOL:  BJGTLF5

LEI:         213800RXPY9WULUSBC04

Total voting rights

As at 7 August 2019, the Company's issued share capital consists of 385,089,449 Ordinary Shares. The total issued share capital with voting rights is 385,089,449.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:

 

Target Fund Managers Limited (Investment Manager to the Company)                                            

Kenneth MacKenzie


+44 1786 845 912

Gordon Bland

 


+44 1786 845 920

Stifel Nicolaus Europe Limited



Mark Young

mark.young@stifel.com

+44 20 7710 7600

Tom Yeadon

tom.yeadon@stifel.com

+44 20 7710 7600

Neil Winward

neil.winward@stifel.com

+44 20 7710 7600




FTI Consulting

TargetHealthcare@fticonsulting.com

+44 20 3727 1000

Dido Laurimore



Claire Turvey

 

Richard Gotla



 

Notes:

 

A copy of this announcement will be available on the Company's website.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCGRGDISXGBGCR
UK 100

Latest directors dealings